Credit Suisse Says Medivation Market Value Is Approaching its Target

By: via Benzinga
Medivation Inc (NASDAQ: MDVN) has rejected a hostile takeover bid by Sanofi SA (ADR) (NYSE: SNY) offering $58 per share in cash with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.